MAPK8 and neoplasm: Whilst further work is required to fully resolve these binding interfaces, the protein-protein interactions uncovered in these studies open up novel therapeutic options for targeting the discrete oncogenic JNK signaling complexes that regulate cancer stem cell populations in specific tumor types.